指南与共识重症综合管理与镇静镇痛

危重症成人谵妄预防和/或治疗干预研究核心结局指标集的测量方法:国际共识研究(Del-COrS)

Measures for the Core Outcome Set for Research Evaluating Interventions to Prevent and/or Treat Delirium in Critically Ill Adults: An International Consensus Study (Del-COrS).
指南 / 共识 · Crit Care Explor · 2023-04-03
一句话结论国际共识推荐用CAM-ICU或ICDSC测谵妄发生与缓解、HADS测情绪困扰、MoCA-Blind测认知,但谵妄严重程度等3个结局未达成共识。

该国际共识研究通过2021年4月三次虚拟会议,由来自六个国家的18名利益相关者(28%为ICU幸存者/家属)对危重症成人谵妄试验核心结局指标集的测量工具和时间窗进行投票,共识阈值预设为≥70%。达成共识的包括:用CAM-ICU或ICDSC测谵妄发生和缓解(100%)、用HADS测情绪困扰(71%)、用MoCA-Blind测认知(83%)。未达成共识的包括EQ-5D五水平测健康相关生活质量(69%)及其6个月测量、IES-R或IES-6测创伤后应激(65%)、纳入谵妄相关情绪困扰的谵妄严重程度测量工具,以及谵妄发生/缓解评估的起止时间和死亡率测定时间。共识认为情绪困扰和认知应测量至出院后12个月。

要点

  • 共识推荐用CAM-ICU或ICDSC测量危重症成人谵妄发生和缓解,共识度100%。
  • 共识推荐用HADS测量情绪困扰(包括焦虑、抑郁、急性应激等),共识度71%。
  • 共识推荐用MoCA-Blind测量认知,共识度83%,且情绪困扰和认知应测量至出院后12个月。
  • EQ-5D五水平测健康相关生活质量仅获69%共识,未达70%阈值,其6个月测量时间也未达成共识。
  • IES-R或IES-6测创伤后应激仅获65%共识,谵妄严重程度(含谵妄相关情绪困扰)的测量工具也未达成共识。

适用人群与场景

  • 危重症成人谵妄预防和/或治疗试验的研究者及相关利益相关者(ICU幸存者/家属、临床医生、研究人员),来自六个国家。

诊断标准与关键阈值

  • 共识阈值:预设为≥70%的投票同意率。

研究设计与关键结果

  • 研究类型:国际共识过程,于2021年4月举行三次虚拟会议。
  • 参与者:18名利益相关者,其中28%为ICU幸存者/家属,来自六个国家。
  • 达成共识的测量工具:CAM-ICU或ICDSC测谵妄发生和缓解(100%);HADS测情绪困扰(71%);MoCA-Blind测认知(83%)。
  • 未达成共识:EQ-5D五水平测健康相关生活质量(69%)及其6个月测量;IES-R或IES-6测创伤后应激(65%);纳入谵妄相关情绪困扰的谵妄严重程度测量工具。
  • 未达成共识的测量时间:谵妄发生和缓解评估的起始与终止时间、死亡率测定时间。
  • 达成共识的测量时间:情绪困扰和认知应测量至出院后12个月。

证据类型、等级与局限

  • 证据类型:国际共识研究(指南类)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在危重症成人谵妄预防或治疗试验中,作者共识推荐使用CAM-ICU或ICDSC测量谵妄发生和缓解、使用HADS测量情绪困扰、使用MoCA-Blind测量认知,并将情绪困扰和认知测量至出院后12个月。
  • 对于健康相关生活质量、创伤后应激和谵妄严重程度(含谵妄相关情绪困扰)的测量工具,以及谵妄评估的起止时间和死亡率测定时间,未达成共识,作者认为需要进一步工作来验证纳入谵妄相关情绪困扰的谵妄严重程度测量工具。

指南或共识出处

  • Del-COrS国际共识研究,发表于Crit Care Explor。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To gain consensus on measurement methods for outcomes (delirium occurrence, severity, time to resolution, mortality, health-related quality of life [HrQoL], emotional distress including anxiety, depression, acute stress, and post-traumatic stress disorder, and cognition) of our Core Outcome Set (COS) for trials of interventions to prevent and/or treat delirium in critically ill adults.

DESIGN: International consensus process.

SETTING: Three virtual meetings (April 2021).

PATIENTS/SUBJECTS: Critical illness survivors/family, clinicians, and researchers from six Countries.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Measures (selected based on instrument validity, existing recommendations, and feasibility) and measurement time horizons were discussed. Participants voted on instruments and measurement timing (a priori consensus threshold ≥ 70%). Eighteen stakeholders (28% ICU survivors/family members) participated. We achieved consensus on the Confusion Assessment Method-ICU or Intensive Care Delirium Screening Checklist to measure delirium occurrence and delirium resolution (100%), Hospital Anxiety and Depression Scale for emotional distress (71%), and Montreal Cognitive Assessment-Blind for cognition (83%). We did not achieve consensus on EQ-5D five-level for HrQoL (69%) or its measurement at 6 months. We also did not achieve consensus on the Impact of Event Scale (IES)-Revised or IES-6 for post-traumatic stress (65%) or on measurement instruments for delirium severity incorporating delirium-related emotional distress. We were unable to gain consensus on when to commence and when to discontinue assessing for delirium occurrence and time to resolution, when to determine mortality. We gained consensus that emotional distress and cognition should be measured up to 12 months from hospital discharge.

CONCLUSIONS: Consensus was reached on measurement instruments for four of seven outcomes in the COS for delirium prevention or treatment trials for critically ill adults. Further work is required to validate instruments for delirium severity that include delirium-related emotional distress.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Rose L, Blackwood B, Needham DM, et al. Measures for the Core Outcome Set for Research Evaluating Interventions to Prevent and/or Treat Delirium in Critically Ill Adults: An International Consensus Study (Del-COrS). Crit Care Explor. 2023. PMID: 37025304. doi:10.1097/CCE.0000000000000884

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。